C

Cyclerion Therapeutics
D

CYCN

1.46000
USD
0.03
(2.10%)
مغلق
حجم التداول
2,624
الربح لكل سهم
-1
العائد الربحي
-
P/E
-1
حجم السوق
3,956,740
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ADVM
    -0.40000
    (-5.51%)
    6.86000 USD
    A
    AQST
    -0.13000
    (-2.84%)
    4.44500 USD
    G
    GRTS
    0
    (0%)
    0.000000 USD
    J
    JAGX
    -0.08040
    (-7.73%)
    0.95960 USD
    R
    RCKT
    -0.810
    (-5.48%)
    13.980 USD
    S
    SELB
    -0.07020
    (-7.39%)
    0.88010 USD
    المزيد
الأخبار

العنوان: Cyclerion Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.